HOME >> BIOLOGY >> NEWS
Activation of receptor ups development of precancerous intestinal polyps

NASHVILLE, Tenn. -- Vanderbilt-Ingram Cancer Center researchers have provided the first evidence that activation of a particular cellular receptor dramatically increases the development of precancerous polyps in the intestine. The findings suggest a new strategy for preventing colorectal cancer by blocking activation of this receptor.

However, they also raise caution about an increased risk of colorectal cancer among people who take drugs that activate this receptor. Such drugs are currently in clinical development to treat obesity and atherosclerosis.

The researchers report their findings Feb. 2 in the online version of the journal Nature Medicine. The paper is scheduled for publication in the print edition next month.

The work was funded in part by the National Colorectal Cancer Research Alliance (NCCRA), an initiative led by NBC's Katie Couric, Lily Tartikoff and the Entertainment Industry Foundation. Other support came from the T.J. Martell Foundation for Leukemia, and the National Cancer Institute.

The group found that among mice with a specific genetic mutation - one that is found among 80 percent of human patients with colorectal cancer - the incidence of larger colon polyps increased fivefold with treatment of a compound known to bind very specifically to the peroxisome proliferator-activated receptor delta (PPAR-delta).

"This is extremely significant because it is these larger polyps that are most likely to develop into intestinal cancer," said Raymond N. DuBois, MD, PhD, Hortense B. Ingram Professor of Molecular Oncology, a professor of Medicine, and associate director of cancer prevention, control and population-based research at Vanderbilt-Ingram.

The team became interested in PPAR-delta's potential role in colorectal cancer development after the observation that the receptor is overexpressed in most colorectal cancer tumors. As part of the lab'
'"/>

Contact: Cynthia Floyd Manley
cynthia.manley@vanderbilt.edu
615-838-0280
Vanderbilt University Medical Center
1-Feb-2004


Page: 1 2 3 4

Related biology news :

1. Scientists Discover New Players On The Gene-Activation Team
2. Researchers Identify A Protein Critical For T Cell Development And Activation
3. CAK Activation Of Plant Cell Cycle: Scientists Find Another Piece In The Jigsaw Puzzle To Help Explain Why Plants Do Not Develop Cancer Spontaneously
4. New Finding Suggests "HATs" Are Key To Gene Activation Puzzle
5. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
6. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
7. Two-pronged attack targeting EGF receptor hinders cancer cell growth
8. Tamoxifen stimulates breast cancer growth following alteration of estrogen receptor
9. Dioxin-receptor network identified
10. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
11. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2019)... ... August 30, 2019 , ... Today marks the introduction ... consumers in the preconception period with doctor-approved products and resources, including The Get ... are trying to get pregnant. , Natalist is built on the values of ...
(Date:8/29/2019)... ... August 28, 2019 , ... Salimetrics, ... passed their five-year milestone of collaboration in salivary bioscience stress research. ... primary focus towards performing feasibility studies, phase 1 – phase 4 clinical ...
(Date:8/27/2019)... ... August 27, 2019 , ... Ambry Genetics ... improve genetic testing guidelines. In the largest cohort study of its kind, Ambry ... at-risk patients. , Clinicians use guidelines to inform decisions about which patients ...
Breaking Biology News(10 mins):
(Date:8/15/2019)... ... August 15, 2019 , ... PathSensors ... Lawrence is a member of the Institute of Food Technologists (IFT) Board of ... Advisory Board, Joint Institute for Food Safety and Applied Nutrition (JIFSAN) Advisory Council ...
(Date:8/8/2019)... ... August 08, 2019 , ... Inference Solutions , ... organizations, today announced that the company’s Studio Intelligent Virtual Agent (IVA) platform earned ... Inference will officially accept the award at Frost & Sullivan’s annual Excellence in ...
(Date:8/6/2019)... (PRWEB) , ... August 06, 2019 , ... ... tools for characterizing microbiome populations down to the strain level, has announced partnerships ... kits and other products to companies and research organizations in Australia, Benelux, Indonesia, ...
(Date:8/4/2019)... ... August 02, 2019 , ... Cirtec Medical Corporation, a strategic outsourcing partner for ... has begun construction on a 30,000 sq. ft. manufacturing facility in the Coyol ... , The facility, which is expected to be fully operational by the end of ...
Breaking Biology Technology:
Cached News: